Salem Investment Counselors’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.4K Hold
327
﹤0.01% 1003
2026
Q1
$5.33K Buy
+327
New +$5.12K ﹤0.01% 959
2025
Q4
Sell
-327
Closed -$4.2K 999
2025
Q3
$4.2K Hold
327
﹤0.01% 1003
2025
Q2
$4.96K Hold
327
﹤0.01% 945
2025
Q1
$5.46K Hold
327
﹤0.01% 920
2024
Q4
$6.16K Sell
327
-280
-46% -$5.4K ﹤0.01% 898
2024
Q3
$11.4K Hold
607
﹤0.01% 828
2024
Q2
$11.5K Hold
607
﹤0.01% 818
2024
Q1
$9.86K Hold
607
﹤0.01% 839
2023
Q4
$7.68K Hold
607
﹤0.01% 857
2023
Q3
$8.26K Hold
607
﹤0.01% 825
2023
Q2
$10.4K Hold
607
﹤0.01% 818
2023
Q1
$8.45K Hold
607
﹤0.01% 841
2022
Q4
$8.12K Hold
607
﹤0.01% 817
2022
Q3
$7K Hold
607
﹤0.01% 822
2022
Q2
$8K Hold
607
﹤0.01% 820
2022
Q1
$8K Hold
607
﹤0.01% 793
2021
Q4
$10K Hold
607
﹤0.01% 834
2021
Q3
$12K Hold
607
﹤0.01% 737
2021
Q2
$14K Hold
607
﹤0.01% 680
2021
Q1
$11K Buy
+607
New +$9.95K ﹤0.01% 665

Other funds holding SEM

Salem Investment Counselors's SEM Position: Q2 2026 in Review

Salem Investment Counselors held its Select Medical (SEM) position steady in Q2 2026 at 327 shares worth $5.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1003.

Salem Investment Counselors first reported a position in SEM in Q1 2021 and has held it in 21 quarters since. The position peaked at $14K in Q2 2021. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Salem Investment Counselors held 327 shares of Select Medical worth $5.4K as of Q2 2026.
  • Salem Investment Counselors left its Select Medical share count unchanged in Q2 2026.
  • Select Medical made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #1003 holding.
  • Salem Investment Counselors first reported a position in Select Medical in Q1 2021 and has held it in 21 quarters since.
  • Salem Investment Counselors's Select Medical position peaked at $14K in Q2 2021.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.